Moleculin Biotech, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Moleculin Biotech, Inc. (MBRX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $174.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-18
- Moleculin Biotech, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $174.00K, a 45.00% increase from fiscal 2024.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $120.00K.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $0.00.
- Moleculin Biotech, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2020 was -$1.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $174.00K 10-K · filed 2026-03-18 | |
| 2024-12-31 | $120.00K 10-K · filed 2026-03-18 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-24 | |
| 2020-12-31 | -$1.00K 10-K · filed 2022-03-24 | $0.00 10-K · filed 2021-03-24 |
| 2019-12-31 | -$38.00K 10-K · filed 2021-03-24 | $38.00K 10-K · filed 2020-03-19 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-19 | |
| 2017-12-31 | -$11.00K 10-K · filed 2019-02-21 | $11.00K 10-K · filed 2018-03-28 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-28 | -$3.00 10-K · filed 2017-04-03 |
| 2015-12-31 | $0.00 10-K · filed 2017-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |